Inogen Inc (INGN) Stock Price, Quote & News

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen...

Industry: Medical Devices

Sector: Healthcare

Phone: 805 562 0500

Website: www.provider.inogen.com

Address:

500 Cummings Center, Suite 2800, Beverly, United States

Estimize Aug. 13 at 8:03 PM

Wall St is expecting 0.01 EPS for $INGN Q3 [Reporting 11/11 AMC] http://www.estimize.com/intro/ingn?chart=historical&metric_name=eps&utm_co

0 · Reply

EarningsInsider Aug. 6 at 10:47 PM

https://www.marketbeat.com/earnings/reports/2026-8-6-inogen-inc-stock/ $INGN Inogen Earnings Transcript

0 · Reply

teachutrades Aug. 6 at 10:00 PM

$INGN thanks to the genius pumping this on reddit made it sound really good, down 10%

0 · Reply

StocktwitsEarnings Aug. 6 at 8:18 PM

$INGN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.14 up 6.67% YoY • Reported revenue of $95.08M up 3.04% YoY • Inogen now expects full year 2026 reported revenue in the range of $355 million to $361 million and adjusted EBITDA of approximately $4.0 million, representing a 48.1% increase from 2025.

0 · Reply

LewisDaKat Aug. 3 at 10:30 PM

$INGN Smartbird Nominates Tech Industry Veterans Elizabeth Mora and Dan Kasun for Election to Its Board of Directors https://marketwirenews.com/stock/ingn/news/smartbird-nominates-tech-industry-veterans-elizabeth-6010493384085063.html?utm_source=stocktwits

0 · Reply

bert400 Jul. 22 at 12:36 PM

$INGN Never turns a profit, decreasing demand, and increasing SG&A spending. Prove me wrong, looking to invest but don’t see the vision.

1 · Reply

BioTuesdays Jul. 2 at 3:39 PM

$INGN has announced the appointment of Andy Reding to the newly created role of chief operating officer (COO), effective Monday, July 6, 2026. https://biotuesdays.com/2026/07/02/inogen-appoints-andy-reding-as-coo/

0 · Reply

SuperGreenToday Jun. 3 at 3:57 PM

$INGN Share Price: $6.05 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.71 – $0.87 Potential Upside: 59% ROI Time to Expiration: 197 Days | Updates via https://fxcapta.com/stockinfo/

1 · Reply

RocketThief May. 18 at 3:53 PM

$INGN at an EV of $63M I continue to believe there is major value here

0 · Reply

StocktwitsEarnings May. 7 at 9:36 PM

$INGN Q1 '26 Earnings Results & Recap Inogen expects Q2 2026 revenue of $94M to $97M and reiterates full-year 2026 revenue guidance of $366M to $373M, reflecting approximately 6.0% growth.

0 · Reply

Inogen Earnings Call Transcript: Q2 2026

Aug 6, 2026, 5:00 PM EDT - 14 days ago

Inogen Earnings release: Q2 2026

Aug 6, 2026, 5:00 PM EDT - 14 days ago

Inogen Slides: Q2 2026

Aug 6, 2026, 5:00 PM EDT - 14 days ago

Inogen Quarterly report: Q2 2026

Aug 6, 2026, 4:05 PM EDT - 14 days ago

Inogen Announces Second Quarter 2026 Financial Results

Aug 6, 2026, 7:00 AM EDT - 15 days ago

Inogen Slides: Corporate presentation

Jul 16, 2026, 8:30 AM EDT - 5 weeks ago

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

2026-07-01T20:10:22.000Z - 7 weeks ago

Inogen names Andy Reding COO

Jul 1, 2026, 4:05 PM EDT - 7 weeks ago

Inogen Announces the Appointment of Andy Reding as Chief Operating Officer

Jun 5, 2026, 1:00 PM EDT - 2 months ago

Inogen Transcript: AGM 2026

2026-05-07T22:49:27.000Z - 3 months ago

Inogen reports Q1 EPS (30c), one estimate (21c)

May 7, 2026, 5:00 PM EDT - 3 months ago

Inogen Earnings Call Transcript: Q1 2026

May 7, 2026, 5:00 PM EDT - 3 months ago

Inogen Slides: Q1 2026

May 7, 2026, 5:00 PM EDT - 3 months ago

Inogen Earnings release: Q1 2026

May 7, 2026, 5:00 PM EDT - 3 months ago

Inogen Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 3 months ago

Inogen Announces First Quarter 2026 Financial Results

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Inogen Proxy statement: Proxy filing

Apr 23, 2026, 8:30 AM EDT - 4 months ago

Inogen to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Inogen Proxy statement: Proxy filing

Apr 14, 2026, 10:15 AM EDT - 4 months ago

Inogen Transcript: 25th Annual Needham Virtual Healthcare Conference

2026-04-07T09:05:10.000Z - 4 months ago

Inogen initiated with a Buy at Freedom Broker

Apr 6, 2026, 4:00 PM EDT - 4 months ago

Inogen Announces the Appointment of Vafa Jamali to Board of Directors

Mar 31, 2026, 8:30 AM EDT - 5 months ago

Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference

2026-03-30T20:16:40.000Z - 5 months ago

Inogen backs FY26 revenue view $366M-$373M, two estimates $368.9M

2026-03-30T20:06:05.000Z - 5 months ago

Inogen names Jason Richardson CFO, Dominic Hulton CMO

2026-03-30T20:05:12.000Z - 5 months ago

Inogen backs Q1 revenue view of in line with 1Q25

Mar 30, 2026, 4:05 PM EDT - 5 months ago

Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 30, 2026, 4:00 PM EDT - 5 months ago

Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth

Mar 17, 2026, 3:00 PM EDT - 5 months ago